NEUE
Income statement / Annual
Last year (2023), NeueHealth, Inc.'s total revenue was $1.16 B,
an increase of 54.53% from the previous year.
In 2023, NeueHealth, Inc.'s net income was -$1.15 B.
See NeueHealth, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
| Operating Revenue |
$1.16 B
|
$751.16 M
|
$1.51 B
|
$514.89 M
|
$280.67 M
|
$130.63 M
|
| Cost of Revenue |
$996.58 M |
$662.97 M |
$1.29 B |
$451.92 M |
$0.00 |
$0.00 |
| Gross Profit |
$164.22 M |
$88.19 M |
$218.88 M |
$62.97 M |
$280.67 M |
$130.63 M |
| Gross Profit Ratio |
0.14 |
0.12 |
0.14 |
0.12 |
1 |
1 |
| Research and Development
Expenses |
$0.00
|
$0.00
|
$0.00
|
$19.43 M
|
$0.00
|
$0.00
|
| General & Administrative
Expenses |
$259.16 M
|
$315.11 M
|
$388.55 M
|
$168.97 M
|
$0.00
|
$0.00
|
| Selling & Marketing
Expenses |
$0.00
|
$82.34 M
|
$76.92 M
|
$34.56 M
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$259.16 M
|
$315.11 M
|
$465.48 M
|
$203.53 M
|
$180.49 M
|
$95.84 M
|
| Other Expenses |
$482.06 M |
$784,000.00 |
$1.23 M |
-$413.12 M |
-$181.02 M |
-$96.87 M |
| Operating Expenses |
$741.22 M |
$385.16 M |
$562.50 M |
$233.35 M |
$181.02 M |
$96.87 M |
| Cost And Expenses |
$1.75 B |
$1.05 B |
$1.86 B |
$685.27 M |
-$405.41 M |
-$193.27 M |
| Interest Income |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$38.20 M |
$12.82 M |
$7.23 M |
$0.00 |
$0.00 |
$0.00 |
| Depreciation &
Amortization |
$18.30 M
|
$30.71 M
|
$35.05 M
|
$8.29 M
|
$1.13 M
|
$1.03 M
|
| EBITDA |
-$566.80 M
|
-$246.39 M
|
-$308.58 M
|
-$249.31 M
|
-$124.20 M
|
-$61.61 M
|
| EBITDA Ratio |
-0.49 |
-0.33 |
-0.2 |
-0.31 |
0 |
0.01 |
| Operating Income Ratio
|
-0.5
|
-0.49
|
-0.23
|
-0.33
|
-0.45
|
-0.48
|
| Total Other
Income/Expenses Net |
-$52.17 M
|
-$84.61 M
|
-$6.00 M
|
-$3.80 M
|
$0.00
|
$0.00
|
| Income Before Tax |
-$629.17 M |
-$381.58 M |
-$349.63 M |
-$170.38 M |
-$125.34 M |
-$62.64 M |
| Income Before Tax Ratio
|
-0.54
|
-0.51
|
-0.23
|
-0.33
|
-0.45
|
-0.48
|
| Income Tax Expense |
-$1.43 M |
$3.66 M |
-$26.52 M |
-$9.16 M |
$0.00 |
$0.00 |
| Net Income |
-$1.15 B |
-$1.46 B |
-$1.18 B |
-$248.44 M |
-$125.34 M |
-$62.64 M |
| Net Income Ratio |
-0.99 |
-1.94 |
-0.78 |
-0.48 |
-0.45 |
-0.48 |
| EPS |
-150.94 |
-185 |
-241.66 |
-32.3 |
-16.03 |
-8.01 |
| EPS Diluted |
-150.94 |
-185 |
-241.66 |
-32.3 |
-16.03 |
-8.01 |
| Weighted Average Shares
Out |
$7.95 M
|
$7.87 M
|
$4.90 M
|
$7.69 M
|
$7.82 M
|
$7.82 M
|
| Weighted Average Shares
Out Diluted |
$7.95 M
|
$7.87 M
|
$4.90 M
|
$7.69 M
|
$7.82 M
|
$7.82 M
|
| Link |
|
|
|
|
|
|
